Vedanta Biosciences

Vedanta Biosciences

  • Founded: 2010
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: C. difficile infection
  • Drug types: INF, NEU, ALL, GI, ONC
  • Lead product: VE303
  • Product link:
  • Funding: $106.5M E Apr 2023; $43M D Jul 2021; $25M D Jan 2021; $12M C Jun 2020; $5.8M CARB-X Dec 2019; $16.6M C-2 Sep 2019; $18.5M C May 2019; $27M C Jan 2019; $50M Jun 2016
  • Investors: AXA IM Alts, The AMR Action Fund, Bill & Melinda Gates Foundation, Skyviews Life Science, Reimagined Ventures, Fiscus Ventures, PEAK6, Atlantic Neptune, K2 HealthVentures, Korea Investment Partners, Korea Investment & Securities Asia Ltd., Korea Investment & Securities US, Inc., PureTech Health, Revelation Partners, QUAD Investment Management, Seventure Partners, Hambro Perks, Pfizer

job board

Short description:

Therapies that modulate pathways of interaction between the human microbiome and the host immune system

Drug notes:

Also Clin2 hepatic encephalopathy; VE416 Clin2 food allergy; VE202 Clin1 IBD; VE800 Clin1 solid tumors; VE707 Clin0 bacterial infections

Long description:

Vedanta Biosciences is developing a class of drugs to modulate the human microbiome. The human microbiome contains trillions of microbes that are important for preserving our health and stimulating immune responses. Dysfunction of the microbiota has been linked with several diseases; however, it is now hoped that the microbiota offers a new target class for therapeutics. Vedanta has one of the largest, most diverse culture collections of gut bacteria in the world and is using their discovery platform to identify defined bacterial consortia with drug-like properties that can be used to create oral therapies. Currently, Vedanta’s pipeline includes product candidates for C.difficile infection, inflammatory bowel disease, Gram-negative infections, solid tumors and food allergies.


Vedanta Biosciences
Senior Systems Administrator
Cambridge, MA|17 days ago
Vedanta Biosciences
Contract - Quality Control Specialist I
Cambridge, MA|41 days ago
Vedanta Biosciences
Head of Commercial
Cambridge, MA|62 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy